Top Markets
#1 Black Phoenix Black Phoenix +355.52%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.17%
#4 Akedo Akedo +48.78%
#5 Acurast Acurast +29.95%
#6 BasedHype BasedHype +23.54%
#7 Cryptopia Cryptopia +21.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.11%
#9 Avantis Avantis +20.16%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +15.50%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Pathfinder Cell Therapy, Inc. Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy, Inc.

PFND
Rank in Stocks #40882
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in... Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$66.72K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Pathfinder Cell Therapy, Inc. (PFND)

Category

Healthcare
Stock price history for Pathfinder Cell Therapy, Inc. (PFND)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.49 on 2000-01-01
Stock price history of Pathfinder Cell Therapy, Inc. from 2000 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -4.50%
2024 0.00%
2023 27.27%
2022 -21.43%
2021 -95.62%
2020 44.91%
2019 23.24%
2018 -41.02%
2017 143.39%
2016 -79.44%
2015 257.08%
2014 -89.60%
2013 -35.40%
2012 -66.73%
2011 -4.69%
2010 -66.98%
2009 27.22%
2008 -77.57%
2007 -36.62%
2006 131.85%
2005 9.98%
2004 12.34%
2003 164.05%
2002 -29.11%
2001 101.01%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $525.55 32.74%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $863.62 33.56%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE